MIRUM PHARMACEUTICALS, INC. INDEMNITY AGREEMENTIndemnity Agreement • July 8th, 2019 • Mirum Pharmaceuticals, Inc. • Pharmaceutical preparations • Delaware
THIS INDEMNITY AGREEMENT (this “Agreement”) dated as of , 2019, is made by and between MIRUM PHARMACEUTICALS, INC., a Delaware corporation (the “Company”), and (“Indemnitee”).
Mirum Pharmaceuticals, Inc. [●] Shares Common Stock ($0.0001 par value) Underwriting AgreementMirum Pharmaceuticals, Inc. • July 8th, 2019 • Pharmaceutical preparations • New York
Mirum Pharmaceuticals, Inc., a corporation organized under the laws of Delaware (the “Company”), proposes to sell to the several underwriters named in Schedule I hereto (the “Underwriters”), for whom you (the “Representatives”) are acting as representatives, [●] shares of common stock, $0.0001 par value (“Common Stock”) of the Company (said shares to be issued and sold by the Company being hereinafter called the “Underwritten Securities”). The Company also proposes to grant to the Underwriters an option to purchase up to [●] additional shares of Common Stock (the “Option Securities”; the Option Securities, together with the Underwritten Securities, being hereinafter called the “Securities”). To the extent there are no additional Underwriters listed on Schedule I hereto other than you, the term Representatives as used herein shall mean you, as Underwriters, and the terms Representatives and Underwriters shall mean either the singular or plural as the context requires.
LICENSE AGREEMENTLicense Agreement • July 8th, 2019 • Mirum Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
For the management of the business and for the conduct of the affairs of the Company, and in further definition, limitation and regulation of the powers of the Company, of its directors and of its stockholders or any class thereof as the case may be, it is further provided that:
